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Summary 
We demonstrate using primary mast cell cultures derived from wild-type and CD45-deficient 
mice that mast cell triggering through the high-affinity immunoglobulin E (IgE) receptor requires 
the cell surface t~osine phosphatase CD45. Unlike wild-type cells, cross-linking of surface-bound 
IgE in mast cells deficient in CD45 does not induce degranulation. Degranulation in these mutant 
cells does occur after treatment with the calcium ionophore A23187 indicating that the degranulation 
machinery is intact in these ceils. We also demonstrate that the tyrosine phosphatase inhibitors 
orthoVanadate and perVanadate inhibit degranulation in wild-type mast ceils, as does cross-linking 
of CD45 by anti-CD45 antibodies. Finally, we show that CD45-deficient mice are resistant to 
IgE-dependent systemic anaphylaxis. These results show that, like the T  call receptor and the 
antigen receptor on B cells, there is an absolute requirement for CD45 in signaling via the high 
affinity IgE receptor, expanding the number of receptors for which CD45 is an essential component. 
~  ergy is  the most common human immune disorder, 
affecting as much as 20% of the Western population. 
The acute allergic response is mediated by mast cells  and 
basophils.  These cells express high affinity receptors for the 
IgE class of antibodies. Cross-linking of surface-bound IgE 
by Ag leads to activation of the cells and the release of granttles 
containing inflammatory mediators such as histamine (1). 
FceRI, the high af~nity IgE receptor, is a four-chain receptor 
complex and a member of the multichain immune recogni- 
tion receptor family (2). After cross-linking of this receptor 
complex, some of the earliest detectable events include tyro- 
sine phosphorylation and activation of cytoplasmic tyrosine 
kinases (3-5), calcium flux (6, 7), and phosphatidyl inositol 
breakdown (8, 9). These events are shared in common with 
other members of the multichain immune recognition receptor 
family including the TCR and the Ag receptor on B cells. 
Recent experiments have shown that the leukocyte common 
antigen (CD45),  a cell surface protein with tyrosine phos- 
phatase activity expressed on all nucleated hemopoietic ceils, 
is an essential component of signaling through both the TCR 
(10-13)  and Ag receptor (14). The similarities in some sig- 
naling properties amongst these different receptor systems 
prompted us to examine the possible role of CD45 in FceRI- 
mediated signaling. 
Materials and Methods 
Cells and Cell Culture.  Supernatants from WEHI-3 cells were 
used as a source of IL-3. Recombinant routine steel factor (SLF)  ~ 
was prepared using bacterial expression and purified by affinity 
purification (Berger, S. A., unpublished observation). Supernatants 
from cells expressing the appropriate vector (obtained from Dr. 
F. Melchers, Basel Institute for Immunology, Basel, Switzerland) 
were used as a source of murine IL-4. Bone marrow from CD45- 
exon 6 -/-  or +/+  littermates were obtained from 6-8-wk-old 
mice and incubated in OPTI-MEM (GIBCO BRL, Gaithersburg, 
MD) plus 5% FCS, antibiotics, and 2-mercaptoethanol. Cells were 
split and refed every 5 d with fresh medium. 
Antibodies.  Anti-CD45 antibodies M1.89 (isotype IgG2b) and 
M1/9.3 were obtained from Dr. M. Julius (Wellesley  Hospital Re- 
search Institute,  Toronto, Canada) and conjugated with fluores- 
cein or biotin.  Antibody M5 (anti-MHC class II) was used as an 
isotype control for flow cytometry. Anti-DNP monoclonal IgE an- 
tibody SPE-7 was purchased from Sigma Chemical Co. (St. Louis, 
MO) and biotinylated. Strepdavidin-PE was used to visualize bi- 
otinylated antibody. 
Degranulation Assay.  CeUs  were washed and incubated in Ty- 
rodds buffer (10 mM Hepes buffer [pH 7.4], 130 raM NaCI, 5 mM 
KCI, 1.4 mM CaC12, 1 mM MgC12, 5.6 mM glucose, 0.1% BSA) 
1 Abbreviations used in this paper: HSA, human serum  albumin; SLF, steel 
factor. 
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(Sigma Chemical Co.) for I h on ice. After removal of excess anti- 
body, cells were exposed to varying amounts of the antigen DNP 
human serum albumin (HSA) (Sigma  Chemical Co.) for 1 h  at 
37~  Stock solutions of the calcium ionophore A23187 (Sigma 
Chemical Co.) were made up in DMSO and diluted in Tyrode's 
buffer. Cells were incubated in A23187 for 1 h at 37~  Degree 
of  degranulation was determined by measuring the release ofa-hexo- 
saminidase  (15). Supernatant dilutions and cell pellets solubilized 
with Tyrode's +  0.5% Triton X-100 were incubated with the sub- 
strate p-Nitrophenyl-N-acetyl-fl-D-glucosamine (Sigma Chemical 
Co.) in 0.1 M NaCitrate (pH 4.5) for 40 rain at 37~  The reac- 
tion was terminated by the addition of 0.2 M glycine (pH 10.7). 
The release of the product 4-p-nitrophenol was followed by absor- 
bance at 405 nm. 
Percent degranulation  =  supernatant activity/(supernatant  + 
pellet activities).  Each determination is the average of three mea- 
surements. 
Preparation of Vanadate  and PerVanadate.  Vanadate was prepared 
by dissolving sodium orthoVanadate  (Sigma  Chemical Co.) to a 
final concentration of 10 mM in 0.2 M Hepes (pH 6). No color 
change was observed indicating the lack of significant decaVana- 
date or Vanadyl ion in the preparation (16). PerVanadate was pre- 
pared by adding an equal concentration of hydrogen peroxide to 
the Vanadate solution. The solutions were used within I h of prep- 
aration. 
Systemic Anaphylaxis.  To observe systemic anapbylaxis, the assay 
described by Ando et al. (17) was used. Briefly, mice primed with 
a monoclonal IgE antibody are challenged 24 b later with Ag. Evan's 
blue dye is included in the challenge to visualize the fluid extrava- 
sation that accompanies the anaphylactic shock. This occurs within 
15-20 min and is manifested by a general blueing of the extremi- 
ties, particularly the front and hind feet, caused by leakage of the 
dye into the tissue.  A  titration of antibody from 20 to 0.01/~g 
was done in  +/+  and  -/-  mice to optimize the discriminatory 
capacity of this assay. 0.1/~g of SPE-7 was found to be an effective 
concentration, with dye extravasation occuring within 10-15 min. 
8-12-wk-old CD45-/-,  +/-, and +/+  littermates (fourth back- 
cross onto C57BL6 background) were injected intravenously with 
0.2 ml PBS and 0.1% BSA containing 0.1/2g IgE anti-DNP anti- 
body SPE-7.20-24 h later, these mice were injected intravenously 
with 0.2 ml PBS containing 0.5% Evan's blue dye with or without 
1 mg DNP-HSA. After 20 rain, the mice were killed and photo- 
graphed. 
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Figure  1.  Flow cytometric analysis of CD45 and IgE Receptor surface expression. (a) +/+  or -/-  mast cell cultures were stained FITC-labeled 
anti-CD45 antibody M1.89 (31) or with a similarly labeled isotype-matched control. Cell staining was analyzed with a FACScan  |  (Becton Dickinson 
& Co., Mountain View, CA). (b)  +/+  or  -/-  mast cell cultures were incubated with biotinylated IgE monoclonal antibody SPE-7, followed by 
incubation with PE-coupled strepdavidin. Control staining was with strepdavidin-PE alone. 
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Primary mast cell cultures were grown from bone marrow 
of +/+  and CD45-exon6 -/-  (hereafter referred to as  -/-) 
mice in the presence of IL-3. By 6 wk, >99%  of the cells 
in the cultures were mast cells, as determined by staining with 
alcian blue or binding of IgE. We confirmed that CD45 was 
expressed on wild-type,  but  not  -/-  mast cells  by flow 
cytometry. Fig. 1 a shows that -/-  cells showed no significant 
staining with the anti-CD45 antibody M1.89, whereas +/+ 
mast cells stained strongly. No significant differences were 
found in the kinetics of mast cell outgrowth or differentia- 
tion in the presence of IL-3 between  +/+  and  -/-  cells. 
We also found that the proliferative response of -/-  mast 
cells to IL-3, IL-4, or SLF was similar to the  +/+  cultures 
(Fig. 2). Taken together, we conclude that the lack of CD45 
does not prevent the emergence and differentiation of bone 
marrow-derived mast cells and that these cells appear to be 
normal in many respects. 
We tested for the ability to degranulate by first priming 
the cells with an IgE monoclonal anti-DNP, followed by in- 
cubation with DNP-HSA to induce receptor cross-linking. 
The degree of mast cell degranulation was determined by mea- 
suring the release of the granule enzyme ~-hexosaminidase. 
As shown in Fig.  3 a,  +/+  mast cells were fully capable 
of degranulation in response to surface IgE cross-linking. In 
contrast, mast cells derived from  -/-  mice were incapable 
of significant degranulation. 
We confirmed that this was not due to an absence of, or 
decrease in IgE receptor. Mast cells from +/+  or  -/-  cul- 
tures were stained with biotinylated IgE and the cell surface 
expression was analyzed by flow cytometry. As shown in Fig. 
1 b both  -/-  and  +/+  mast cell cultures stain strongly 
for IgE with a similar mean fluorescence intensity. The broader 
distribution of staining in the +/+  cultures suggests some- 
what greater heterogeneity of IgE receptor expression. How- 
ever other cultures initiated at different times do not show 
such a broad distribution. 
Calcium flux is an early event after FceRI cross-linking 
(6, 7) and calcium ionophores are well known to be able to 
bypass the requirement for IgE receptor cross-linking in de- 
granulation (18,  19). We used this property to confirm that 
Figure  2.  +/+ and  -/-  mast 
cells respond equally to IL-3, IL-4, 
and SLE Two separate cultures of 
+/+ or -/-  mast cells were es- 
tablished. At the time of the ex- 
periment,  culture A was 9 wk old 
and culture B was 5 wk old. Cells 
were grown for 7 d in either a 1:50 
dilution  of medium  from  cells 
producing  I1.-3 or II.-4, or  100 
ng/ml of SLF. Cells were pulsed 
with [3H]thymidine and incorpo- 
rated  counts  were  determined 
using scintillation counting,  m.a. 
refers to cells cultured in medium 
alone. 
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Degranulation in response to cross-linking  antigen or cal- 
cium ionophore.  (a) Degranulation by  +/+  or  -/-  mast cells after ex- 
posure to cross-linking Ag. (b) Degranulation by +/+ or -/-  mast cells 
after exposure  to the calcium  ionophore A23187. 
-/-  mast cells are capable of degranulation. As shown in 
Fig.  3  b,  both  +/+  and  -/-  mast cells are capable of a 
similar degree of degranulation after incubation with the cal- 
cium ionophore A23187. This indicates that the degranula- 
tion machinery is intact in  -/-  cells  and that the failure 
of -/-  mast cells to degranulate in response to receptor cross- 
linking reflects the requirement of CD45 in FceRI receptor 
signaling. 
CD45  is highly expressed on hemopoietic cells and can 
represent upwards of 10%  total cell surface protein (20).  It 
is possible  that the absence of CD45 expression throughout 
development results in secondary alterations in the -/-  mast 
cell population which are responsible for the inability of -/- 
cells to degranulate in response to FceRI receptor cross-linking. 
One prediction of this hypothesis is that short-term inhibi- 
tory treatments directed against CD45 in normal cells would 
have no effect on degranulation.  To address this question, 
we treated +/+  cells with both nonspecific and specific agents 
active against the CD45  tyrosine phosphatase. 
In one series of experiments, we treated the cells with the 
tyrosine phosphatase inhibitors orthoVanadate or perVanadate. 
As shown in Fig.  4,  both agents are capable of significant 
inhibition  of specific  degranulation.  As reported in  other 
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Figure 4.  Effect  of Vanadate  or 
perVanadate on specific degranu- 
lation by  +/+  mast cells. Cells 
were primed with anti-DNP an- 
tibody and then incubated for 1 h 
at 37~  with either Vanadate or 
perVanadate. 10 ng/ml of DNP- 
HSA was added to indue, degran- 
ulation. After a further 1-h incu- 
bation at 37~  degranuhtion was 
measured  by the release  of/3-hexo- 
saminidase.  Specific  degranulation 
was  calculated  by  subtracting 
background degranuhtion (in the 
absence  of added DNP-HSA) from 
degranulation in the presence of 
antigen. 
systems (21, 22), perVanadate is much more potent than or- 
thoVanadate, both in maximal amount of inhibition and con- 
centration required. 
Both orthoVanadate and perVandate are relatively nonspecifc 
phosphatase inhibitors. We therefore also tested for the ability 
of specific anti-CD45 antibodies to inhibit degranulation. Al- 
though the anti-CD45 antibody M1.93 failed to inhibit de- 
granulation when incubated with mast cells (not shown), 
significant inhibition of degranulation could be achieved when 
cells were incubated with biotinylated M1.93  followed by 
aggregation with streptavidin (Fig.  5). Our interpretation 
of these results is that cross-linking of CD45 causes aggrega- 
tion that inactivates the FceKI-CD45 complex whereas in- 
cubation with the antibody alone does not disrupt this com- 
plex.  This result is similar to those obtained from CD45 
cross-linking studies on T  cells (23). 
Since mast cells are the primary mediators of the acute al- 
lergic response in vivo, our in vitro results would predict that 
CD45-deficient mice are resistant to IgE-mediated anaphylaxis. 
To test this hypothesis, CD45-/-,  +/-, and +/+  mice were 
injected with anti-DNP IgE antibody, followed by challenge 
with antigen 20-24 h later. Evan's blue dye was included in 
the antigenic challenge to visualize the fluid extravasation that 
occurs during anaphylaxis. As shown in Fig. 6, 20 rain after 
the antigenic challenge, +/+  and +/-  mice showed a marked 
blue coloring in the feet (and other extremities), whereas  -/- 
mice showed no dye extravasation  above background levels. 
These results indicate that  -/-  mice are resistant to IgE- 
mediated anaphylaxis. 
In T cells, the primary role of CD45 is the dephosphory- 
lation of the tyrosine kinases p56  ~k (24, 25) and p59fy" (26). 
This activates these kinases, leading to increased tyrosine phos- 
phorylation of substrates.  Similarly, in B cells, CD45 may 
be responsible for activating src-like tyrosine kinases as well 
(14, 27).  Studies have shown that the tyrosine kinases lyn, 
yes, and ptk72 are activated in mast cell or basophil cell lines 
(3-5).  It remains to be determined if CD45 is responsible 
for activating these kinases in primary mast cell cultures. 
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Figure 5.  Anti-CD45 antibody M1.93 inhibits degranulation when 
cross-linked by strepdavidin. +/+ cells were incubated with IgE antibody 
and biotinylated anti-CD45 antibody M1.93 on ice for 1 h. Excess anti- 
body was washed off and cells were then incubated with strepdavidin for 
1 h at 37~  10 ng/ml of DNP-HSA was added to induce degranulation 
and the incubation  was continued for another hour at 37~  Percent de- 
granulation was measured by the release of B-hexosaminidase. Using the 
Student's t test distribution, the probability that the percent degranula- 
tion is not different in the presence of cross-linking agent (p value) is 0.0003 
and 0.0007 for  100 ng/ml and 1,000 ng/ml, respectively. 
Mast cells from -/-  mice are fully capable of responding 
to signals from the growth factor SLF and the cytokines IL-3 
and IL-4. In addition, a previous study (13) found that colony 
formation by bone marrow-derived hemopoietic cells was 
normal in response to IL-3. In contrast, Broxmeyer et al. (28) 
reported that antisense oligodeoxynudeotides to CD45, or 
cross-linking anti-CD45 antibodies could inhibit colony for- 
mation by human bone marrow cells in response to GM-CSF, 
IL-3, and SLF. These results may reflect different requirements 
or involvement  of CD45 in human bone marrow progenitors. 
Hook et al. (29) found that extensive incubation of human 
basophils with anti-CD45 antibodies was required for inhi- 
bition of degranulation. We find that incubation of mast cells 
for a short time with antibody alone is ineffective in inhibiting 
degranulation, but that significant inhibition can be obtained 
if the cell surface CD45 is cross-linked.  It is possible that 
the longer incubation times used by Hook et al. (29) are re- 
quired for significant inhibition. Alternatively, inhibition by 
anti-CD45 antibodies may be epitope specific. We are cur- 
rently testing other known anti-CD45 antibodies to deter- 
mine their ability to inhibit mast cell degranulation. 
It is generally accepted that mast cells and basophils are 
the primary mediators of the acute allergic response. Recently 
Dombrowicz et al. (30), using mice genetically deleted for 
the oe-chain of the Fcelkl receptor,  were able to show that 
these mice were resistant to anaphylaxis. These results confirm 
that it is signaling through the high affinity IgE receptor 
that is required for the acute allergic response. Our observa- 
tion that CD45-defdent mice are also resistant to anaphylaxis 
provides additional evidence for the involvement of CD45 
474  CD45 and Mast Cell Degranulation Figure  6.  CD45-deficient mice are resistant to IgE-mediated systemic anaphylaxis. +/+,  +/-, and  -/-  mice were injected intravenously with 
0.2 ml PBS containing 0.1% BSA and 0.1 #g IgE anti-DNP  monoclonal SPE-7. 20 h later, these mice were injected intravenously with 0.2 ml PBS 
containing 1 mg DNIa-HSA and 0.5% Evan's blue dye. 20 min after the Ag challenge, the mice were killed and photographed. The photograph shows 
the hind feet of +/+,  +/-,  and  -/-  animals. Control mice injected with Evan's blue dye only showed no dye extravasation. 
in signaling through the FceK1 pathway and confirms the 
importance of this signaling pathway in the anaphylactic re- 
sponse. 
The IgE receptor system is the third example of a mul- 
tichain immune recognition receptor requiring CD45 for ac- 
tivation. Other members of this family include the high and 
low affinity  IgG receptors, which display  significant  homology 
to the FceRI receptor. It is therefore possible that all members 
of this family require CD45 as an essential component of 
the signaling complex. 
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